Karolinska Development
Logotype for Karolinska Development

Karolinska Development (KDEV) investor relations material

Karolinska Development Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Karolinska Development
Q4 2025 earnings summary13 Feb, 2026

Executive summary

  • Net loss for 2025 was SEK -193.9 million, a significant decline from SEK -8.1 million in 2024, driven by negative fair value changes in portfolio companies and earn-out agreements.

  • Net asset value at year-end was SEK 1,044.7 million (SEK 3.9 per share), down from SEK 1,245.0 million (SEK 4.6 per share) at the end of 2024.

  • Portfolio fair value decreased to SEK 1,327.4 million from SEK 1,451.5 million year-over-year, mainly due to dilution in PharmNovo and a downturn in Modus Therapeutics.

  • Cash and cash equivalents at year-end were SEK 23.9 million, down from SEK 42.0 million in 2024.

  • No dividend proposed for 2025.

Financial highlights

  • Revenue for 2025 was SEK 1.7 million, slightly down from SEK 1.8 million in 2024.

  • Change in fair value of shares in portfolio companies was SEK -115.6 million for the year (SEK 1.6 million in 2024).

  • Change in fair value of other financial assets and liabilities (earn-outs) was SEK -63.8 million (SEK 15.4 million in 2024), mainly due to the discontinued OG-6219 program at Organon.

  • Operating loss for the year was SEK -194.1 million (SEK -9.2 million in 2024).

  • Investments in portfolio companies totaled SEK 61.8 million (SEK 62.0 million in 2024).

Outlook and guidance

  • A rights issue in January 2026 raised SEK 115 million before costs, strengthening the financial position for continued support of portfolio companies.

  • Several portfolio companies are expected to report key clinical trial results in 2026–2027, potentially enabling attractive exits or licensing deals.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Karolinska Development earnings date

Logotype for Karolinska Development
Q1 202630 Apr, 2026
Karolinska Development
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Karolinska Development earnings date

Logotype for Karolinska Development
Q1 202630 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Karolinska Development AB is a Sweden-based investment company that plays a significant role in the biotechnology sector. It is primarily engaged in providing capital, developing, and commercializing biotechnological products. The company's activities span a broad range of medical and therapeutic areas, including oncology, infections and wound healing, women’s health, cardiovascular and hematology, as well as medical equipment and diagnostics. Karolinska Development AB showcases a diverse portfolio that comprises investments in pharmaceutical research and development, healthcare technology, gene research and development, drug delivery technologies, and life sciences tools, among others. Founded in 2003 and with a modest team, the company focuses on fostering innovation and advancing the development of new treatments and medical solutions. The company is headquartered in Solna, Sweden, and its shares are listed on the Stockholm Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage